Company

Xenon Pharmaceuticals Inc XENE

Tracked across 2 disclosed holders on Protégé.

Held by these investors

Investor% of portfolioValue
Stanley Druckenmiller0.3%$14.4M
Baker Brothers Investments0.1%$22.3M

Open the full company deep-dive →